Information about Immunis
My details
*
*
*

Immunis (SRL)

BE 0883.690.091

Kaperberg 7, 4700 Eupen

Company information

Status
Active

Enterprise number

BE0883.690.091

VAT liability
Yes
Established
21-09-2006
Last balance sheet year
2024
Company size
Small 2,5 FTE
Principal activity
Accounting, bookkeeping, auditing activities and tax consultancy
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Immunis

2024 2023 2022 2021
Profit/Loss € 491,183 10 % € 444,593 27 % € 350,805 2 % € 343,515
Equity € 6,124 -7 % € 6,577 -17 % € 7,898 -32 % € 11,672
Gross margin € 638,777 5 % € 607,854 24 % € 491,940 9 % € 453,001
Employees 2.5 2.1 2.5 1.9

Publications from Immunis

Date Publication
27-03-2023 Resignations, Appointments - Modification Legal Form (FR)
05-01-2023 Resignations, Appointments (FR)
07-02-2022 Capital, Shares - General meeting (FR)
28-11-2017 Resignations, Appointments (FR)
27-01-2010 Resignations, Appointments (FR)

Frequently asked questions

What is the VAT number of Immunis?
The VAT number of Immunis is BE 0883.690.091.
Wat is the PEPPOL ID of Immunis?
The PEPPOL ID of Immunis is 0208:0883690091. Log in or start a free trial to see the full overview.
When was Immunis founded?
Immunis was founded on 21-09-2006.
What is the address of Immunis?
The current registered office of Immunis is located at Kaperberg 7, 4700 Eupen.
When was the last time Immunis filed their annual financial statements?
The most recent financial statements of Immunis were filed on 06-06-2025.
How many employees does Immunis have?
There are 2,5 FTEs working at Immunis according to the staff figures in the most recent financial statements.
What is the annual turnover of Immunis?
At the time of its most recent financial statements, Immunis did not publish any turnover figures. Immunis reported a gross margin of €638,777.00.

Sources